A new study published in the Journal of Neuroimmunology1 indicates that disease severity of muscle-specific kinase (MuSK) myasthenia gravis (MG) could be linked to MuSK antibody levels. The ...

An fresh look at trial results that propelled the only FDA approval of a chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma (MCL) shows prior treatment with ibrutinib, a ...

Adults living with idiopathic hypersomnia and narcolepsy type 1 often report cognitive difficulties, including problems with memory, attention, and mental fatigue. However, new research published in ...

The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...

In this interview with the study’s lead author, Sarah M. Lima, PhD, MPH, an epidemiologist and postdoctoral fellow in cancer populations at the Georgetown Lombardi Comprehensive Cancer Center, she ...

The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...

Importantly, several studies evaluated CBT-I as an adjunct to usual care for comorbid mental health conditions such as ...

A new study links telomere length genetics to IPF risk, showing how rare variants and polygenic scores may guide future screening and precision care.

Study finds breast cancer survival gaps tied to historical redlining narrowed over time, though newer therapies may be widening disparities again.

New reports reveal rising insurance costs, senior drug savings, and cancer care inequities, showing how policy and ...

However, quitting smoking lowers the risks of at least 12 different types of cancer, including cancers of the lung, liver, and esophagus. The longer an individual remains smoke free, the more their ...